Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/27/2025

Acyclovir Dosing for Chickenpox

Pediatric Dosing (Immunocompetent)

  • The Centers for Disease Control and Prevention recommends oral acyclovir 20 mg/kg per dose (maximum 800 mg/dose) four times daily for 5-7 days for immunocompetent children with chickenpox, initiated within 24 hours of rash onset for maximum benefit 1, 2
  • For children with mild to moderate immunosuppression, oral acyclovir 20 mg/kg four times daily (maximum 800 mg/dose) for 7-10 days may be used 1, 2

Immunocompromised Pediatric Patients

  • The Centers for Disease Control and Prevention recommends intravenous acyclovir 10 mg/kg every 8 hours (or 500 mg/m² every 8 hours as alternative) for children with severe immunosuppression (HIV CDC category 3 or equivalent) 1, 2, 3
  • The treatment duration for immunocompromised pediatric patients is 7-10 days or until no new lesions for 48 hours 1, 2

Alternative Agent: Valacyclovir

  • The CDC emphasizes that acyclovir remains preferred for pediatric chickenpox due to established efficacy and available liquid formulations, although valacyclovir may be used for older children and adolescents able to swallow tablets 1, 2, 4, 5